OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-09-30-accounts

Unrestricted
Notes Fundsf 2021
6		 2020
6
Income and Endowments from:
Donations
and legacies		 11,735
Other trading activities 12,895 12,895 7,360
Total income 12,895 12,895 19,095
Expenditure
Expenditure on charitable activities 8,674 8,674 21,798
Total expenditure 8,674 8,674 21,798
Net Income/(expenditure) and net movement in funds for the
year 4,221 4,221 (2,703)
Reconciliation
offunds
Total funds, brought
forward		 93,922 93,922 96,625
Total funds, carried forward 13 98,143 98,143 93,922

DONATI ONS AND LEGACIES
Unrestricted
Funds 2021 2020
6 6 6
Donation from BEAVRS Trading Ltd 11,735
2020 11,735 11,735
INCOME FROM OTHER TRADING ACTIVITIES
Unrestricted
Fundsf 2021f 2020f
Membership subscriptions 12,895 12,895 7,360
12,895 12,895 7,360
2020 7,360 7,360
ANALYS IS OF EXPENDITURE
Research & Retinal
education Outcomes
projects Project 2021 2020
6 6 6 6
Direct project costs 4,194 4,194 15,274
Support costs (note 5) 2,171 2,171 3,353
Governance costs (note 5) 2,309 2,309 3,171
8,674 8,674 21,798
2020 16,524 5,274 21,798

llocated to ac tivities at different percent ages,
based on direct projec		 t costs attributable to each ac tivity.
General Governance
support
f		 costs
f		 2021
f		 2020
6
Management costs 1,504 1,504 2,369
Computer costs 28 28 13
Bank charges 578 578 401
Other support costs 61 61 570
Accountancy fees 2,309 2,309 3,171
2,171 2,309 4,480 6,524
2020 3,353 3,171 6,524

2021 2020
F E
2,309 3,171

2021 2020
E E
Shares
in group undertakings		 and participating interests
Shares
in group undertakings		 and participating interests:
Subsidiary
Undertakings Total
Cost E
At 1 October 2020 1
At 30 September 2021
Net book value
At 30 September 2021
At 30 September 2020
Country of Country of Proportion ofvoting ofvoting Principal
Undertaking incorporation Holding rights and shares held activity
2021 2020
Subsidiary undertakings
BEAVRS Trading Ltd United Kingdom Ordinary shares 100% 100% Provision of
seminars and
exhibitions for
Vitreoretinal
Surgeons
The summary
f		 inancial
performance
ofthe subsidiary		 is:
2021 2020
6 6
Turnover 15,718 91,865
Cost ofsales (3,620) (51,967)
Administrative expenses (25,692) (24,530)
Net profit/(loss) (13,594 15,368
Current assets 58,085 50,339
Current
liabilities		 (59,943) (38,603)
Net assets 1,858 11,736
Total equity (1,858 11,736

2021f 2020
6
Trade debtors 6,145 3,155
Due from group undertakings 2,130 2,300
Accrued income 11,735
Other debtors 58,577 58,577
66,852 75,767
CASH AND CASH EQUIVALENTS
2021 2020
6 6
Cash at bank 65,906 62,439

CREDITORS: amounts
falling due within one year
2021 2020
F F
Trade creditors 1,657 3,201
Accruals 22,134 32,499
Deferred income (note 12) 4,960 2,720
Other creditors 5,865 5,865
34,616 44,285
2021 2020
6 6
Balance as at 1stOctober 2,720 3,895
Amounts released from previous periods (2,720) (3,895)
Resources deferred in the period 4,960 2,720
Balance as at 30th September 4,960 2,720

Balance at Balance at
01.10.2020 Income Expenditure Transfers 30.09.2021
6 8 8 6 8
Unrestricted Funds:
General funds 93,922 12,895 8,674 98,143
Total funds 93,922 12,895 8,674 98,143
Movement in funds —previous year:
Balance at Balance at
01.10.2019
f		 Income
6		 Expenditure
6		 Transfers
8		 30.09.2020
6
Restricted Funds:
Retinal Outcomes Project 2,427 5,274 2,847
Unrestricted Funds:
General funds 94,198 19,095 16,524 (2,847) 93,922
Total funds 96,625 19,095 21,798 93,922

ANALY SIS OF NET ASSETS B ETWEEN FUNDS
Unrestricted Restricted Total
6 8 8
Fixed assets/investments 1 1
Current assets 132,758 132,758
Current liabilities (34,616) (34,616)
Total net assets 98,143 98,143
Analysis of net assets between funds —previous year:
Unrestricted Restricted Total
6 F 6
Fixed assets/investments 1 1
Current assets 138,206 138,206
Current liabilities (44,285) (44,285)
Total net assets 93,922 93,922